Clearmind Medicine (FRA:CWY0) Total Stockholders Equity : €4.63 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Total Stockholders Equity?

Clearmind Medicine's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €4.63 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Clearmind Medicine's Book Value per Share for the quarter that ended in Jan. 2024 was €1.46. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Clearmind Medicine's Debt-to-Equity for the quarter that ended in Jan. 2024 was 0.02.

Clearmind Medicine Total Stockholders Equity Historical Data

The historical data trend for Clearmind Medicine's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Total Stockholders Equity Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Stockholders Equity

Get a 7-Day Free Trial

0.09

0.32

3.34

-0.83

0.67

Clearmind Medicine Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Stockholders Equity	Get a 7-Day Free Trial															3.57	2.23	1.93	0.67	4.63

Clearmind Medicine (FRA:CWY0) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Clearmind Medicine's Book Value per Share for the quarter that ended in Jan. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4.628	-	0)	/	3.16957
	=	1.46

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Clearmind Medicine's Debt-to-Equity for the quarter that ended in Jan. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.059	+	0.028)	/	4.628
	=	0.02

Clearmind Medicine Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (FRA:CWY0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (FRA:CWY0) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CMND:USA CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (FRA:CWY0) Headlines

No Headlines